Equity Market Research
Wednesday, 31 May 2017
AUROBINDO PHARMA: Better off compared to peers; positive outlook for FY18 says Motilal Oswal https://goo.gl/pluo29
AUROBINDO PHARMA: Better off compared to peers; positive outlook for FY18 says Motilal Oswal https://goo.gl/pluo29
https://goo.gl/pluo29
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment